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Iodine nutrition in Brazil: 
where do we stand?
Iodo nutricional no Brasil: como estamos?
Geraldo Medeiros-Neto1 
ABSTRACT
Brazilian legislation, since 1955, failed to achieve its objectives because the issue was not pro-
perly addressed: iodized salt was only available in endemic areas, at a low amount of 10 mg 
Iodine/kg salt. Lack of surveillance and cooperation were common errors.  From 1982 to 1992, 
the INAN distributed potassium iodate to the industry free of charge, but it was abolished in 
1991. Only four years later (1995) was a new law enacted effective in determining that all salt 
for human use should be iodized at levels established by the Health Authorities. During the 
period comprising 1998 to 2004, excessive iodination of salt (40 to 100 mg/kg) could lead to an 
increased prevalence of chronic autoimmune thyroiditis and iodine-induced hyperthyroidism. 
In 2003, the content of iodine/kg of salt was lowered to 20 to 60 mg I/kg salt. A national survey of 
schoolchildren is currently underway and will indicate the changes required for adequate iodine 
in salt for human use. Arq Bras Endocrinol Metab. 2009;53(4):470-4.
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RESUMO
A legislação para corrigir deficiência crônica de iodo no Brasil iniciou-se em 1955. O sal iodado 
seria distribuído somente em áreas endêmicas de bócio, com dose fixa de 10 mg Iodo/kg de sal. 
Na década de 1982 a 1992, o Instituto Nacional de Alimentação e Nutrição assumiu o Programa 
Nacional para a Deficiência Crônica de Iodo e forneceu o iodato de potássio a todos os produ-
tores de sal. Em 1992, o INAN foi dissolvido. Nova legislação foi promulgada em 1995. A Anvisa 
ficou encarregada de supervisionar o teor de iodo em amostras de sal. No período de 1998 a 
2004, o teor de iodo no sal foi elevado para 40 a 100 mg I/kg de sal. O excesso nutricional de 
iodo na população possivelmente aumentou a prevalência de tireoidite de Hashimoto e hiperti-
reoidismo. Inquérito epidemiológico nacional (PNAISAL) em escolares, em execução, indicará 
as futuras determinações para a adição de iodo no sal. Arq Bras Endocrinol Metab. 2009;53(4):470-4.
Descritores
Iodo nutricional; excesso de iodo; hipertireoidismo; hipotireoidismo; moléstias autoimunes tireoideas
INTRODUCTION
Since colonial times, iodine deficiency disorders have been a major cause of goiter in the Brazilian popu-
lation, having been described by several scientific expe-
ditions that ventured deep into Brazil’s hinterland (1). 
But although goiter is a visible and easily detectable 
anomaly, the most serious sequelae of iodine deficiency 
disorders is brain damage to fetus and infants. Inde-
ed, several reports confirm that mild to severe iodine 
deficiency induces some degree of brain defects, with 
post-natal sequelae such as mental deficiency, abnormal 
neurological signs and deaf mutism (2). Thus, several 
countries in Europe introduced iodized salt in order 
to prevent the consequences of iodine deficiency. Only 
in 1953 were the first steps taken in Brazil following 
the introduction of iodized salt, albeit restricted to are-
as recognized as iodine deficient (Table 1). This legal 
ruling posed an almost impossible task for the health 
authorities and the salt industry. How could possibly 
the distribution of iodized salt only to areas defined as 
“endemic” be organized, while other areas of the coun-
try were to continue using non-iodized salt? 
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Table 1. Legislation on iodine fortification of salt for human use in Brazil
Law 1944, August 14, 1953: iodination of salt for human use is made 
mandatory, but only in areas with endemic goiter
Amendment in 1956: iodized salt is extended for all salt for human use. The 
Ministry of Health is to import and distribute potassium iodate
Law 6150, Dec. 3, 1974: salt iodination is set at 10 mg/kg and the salt 
industry is responsible for the purchase and fortification of salt at their own 
expense. Surveillance is to be performed by the individual States and districts
Law 9005, March 16, 1995: * the amount of iodine for fortification of salt for 
human use is established by the Ministry of Health which is to import and 
distribute potassium iodate to the salt industry without charge. Surveillance of the 
content of iodine/kg of salt to be conducted by Anvisa**
* In 1998, Anvisa increased the amount of iodine in salt for human use to 40-100 mg Iodine/kg salt.
** In 2003, the amount of iodine in salt for human use was reduced to 20 to 60 mg I/kg salt.
FURTHER LEGISLATION ON SALT IODINATION
After three years, this situation was recognized as logistical-
ly unworkable and in 1956, iodized salt was made widely 
available to Brazil’s population as a whole (Table 1). The 
Ministry of Health was charged with the task of importing 
potassium iodate for distribution to the salt mills. Again, 
the whole strategy of adding iodine to salt was hampered 
because, in brief, small salt mills never added potassium 
iodate to the salt they produced, in spite of receiving this 
iodine source from the health authorities. Successive na-
tional surveys of schoolchildren were conducted in 1955 
(24.6% of the Brazilian children were goitrous), and again 
in 1975 (when 14.7% of the children had palpable goi-
ters). This latter figure indicated that approximately 10 
million Brazilians were likely suffering from iodine defi-
ciency (out of a population of 60 million).
Thus, another law was enacted by the House of Rep-
resentatives (Table 1), determining that the amount of 
iodine in salt for human consumption was to be set at 
10 mg iodine/kg salt. Moreover, this new law trans-
ferred the onus of purchasing potassium iodate to the 
salt industry. Obviously, this was ineffective because 
each State of the Republic of Brazil was then respon-
sible for the surveillance of salt supplied for human use 
by checking samples of salt on the market and also at 
salt mills, although this was seldom done.
CREATION OF TASK FORM TO SAVE THE 
IODINATION PROGRAMME
The situation was so badly conducted that in 1982 the 
National Institute for Food and Nutrition (INAN) of 
the Ministry of Health decided to create a Working Task 
Force to solve the problem. This new task force included 
members of the Salt Industry, Health Authorities, and 
expert consultant from the Universities of Pernambuco 
and São Paulo (GMN). The Committee decided that 
the solution would be to provide Potassium Iodate free 
of charge to the salt mills, but the industry would have 
to agree a system of close surveillance whereby samples 
of salt would be periodically tested both on the market 
and on the production line. If below or above legal con-
centrations of iodine/kg were detected, the salt mills 
would be fined and possibly closed down. 
Therefore, between 1982 and 1992, it can be as-
sured that the Brazilian population had received iodine 
through an effective salt iodination program coordi-
nated by the INAN Committee, with full cooperation 
of the salt industry. About seven thousand samples of 
salt were analyzed each year, and INAN published the 
results annually in an internal bulletin.
SALT IODINATION PROGRAMME INTERRUPTED IN 
1992
In 1992, there was a legal dispute based on the fact 
that supplying the salt industry with free potassium io-
date was illegal according to the 1974 law (Table 1). 
Therefore, during the proceeding three years most of 
the salt consumed by the Brazilian population was not 
iodized. The largest salt mills, however, continued to 
add iodine to their salt at their own expense. In 1994 
and 1995, a Third National Survey in schoolchildren 
was conducted and aside from goiter prevalence io-
dine urinary excretion was assayed. Four deficient areas 
and 116 moderately deficient villages were detected. 
This work indicates that iodine deficient is still pres-
ent mostly in the impoverished area of Northeast Brazil 
(3). Finally, in 1995, a new law was approved by the 
House of Representatives and the Senate, and signed 
by the President of the Republic of Brazil (Table 1). 
The law simply stated that all salt for human use should 
be iodinated according to the limits and rules set forth 
by the Ministry of Health. During the same period, it 
was agreed that surveillance and monitoring should be 
conducted by the National Agency for Sanitary Surveil-
lance (Anvisa). The limits for salt iodination were set at 
40 to 60 mg iodine/kg of salt.
NEW LIMITS FOR SALT IODINATION
In 1998, Anvisa decided to increase the concentration of 
iodine in the salt for human use to 40 to 100 mg iodine/
kg of salt. The rationale was to provide a broader range 
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so as to avoid salt producers from introducing less (< 
40 µg) or more (> 100 µg/L) iodine to salt. In either cir-
cumstance, the salt industry would be fined accordingly.
For the ensuing five years (1998-2003), the Brazil-
ian population was subjected to excessive iodine nutri-
tion due to the relatively high content of iodine in the 
salt. This was confirmed by the studies linked to the 
Thyromobil Project in 2001 (4). In this field work, it 
was confirmed that schoolchildren were receiving exces-
sive iodine nutrition. Indeed, almost 86% of all children 
examined excreted more than 300 µg iodine/L of urine 
(Table 2). Moreover, close to 50% of all salt samples (col-
lected at homes) contained more than 60 mg iodine/kg 
of salt. Therefore, in 2003, the Anvisa agency decided 
to lower the iodine concentration of salt for human use 
to 20-60 mg iodine/kg of salt (Table 3).
Table 3. Salt for human use in Brazil (t = tons)
Year Total (salt consumed)(t)
Other Uses *1
(t)
Ingested
(t)
Population
(*2, x 103) 
Daily consumption (*3)
 Total
(g/day)g/person/day
Direct      Indirect
1998 793,300 87,260 706,040 161,790 8.96 2.99 11.95
1999 793,900 87,330 706,570 163,947 8.85 2.96 11.81
2000 764,700 84,120 680,580 166,112 8.89 2.30 11.19
2001 759,900 83,590 676,310 172,385 8.05 2.69 10.74
2002 788,500 86,730 701,770 174,632 7.77 3.24 11.01
2003 798,900 87,880 711,020 181,581 7.57 3.44 11.01
2004 856,700 94,240 762,460 184,184 8.01 3.46 11.47
2005 875,800 96,340 779,460 184,784 8.14 3.45 11.59
2006 895,200 98,470 796,730 186,770 8.26 3.43 11.69
2007 931,400 102,450 828,950 183,987 8.62 3.72 12.34
Source: ABERSAL, 2008.
* 1 Salt used in preservation of food.
* 2 Source: IBGE (Brazilian Institute for Geography and Statistics).
* 3 Salt used domestically (direct) and ingested in industrialized food (indirect).
Table 2. Urinary iodine excretion (µg I/L) in schoolchildren during the Thyromobil 
project (May to June, 2000)*
State Samples(n)
Median
(µg/L)
Urinary Iodine excretion 
(µg/L)
101-200 201-300 > 300
Maranhão 205 220 33.5 66.6 -
Tocantins 188 315 - 25.0 75.0
Goiás 187 360 - 33.3 66.6
Mato Grosso   95 520 -   2.0 98.0
Mato Grosso do Sul 239 480 -   3.0 97.0
Minas Gerais   99 501 -  4.0 96.0
Total   1.013 360 - 22.3 86.1
*Assays of urinary iodine were conducted at the Universidad Peruana Cayetano Heredia, Lima, Peru 
(Prof. Eduardo Pretell).
EFFECTS OF EXCESSIVE IODINE INTAKE ON THE 
POPULATION
Excessive iodine intake for a prolonged period of time 
may be harmful. The WHO states that iodine excess 
may increase the prevalence of chronic autoimmune 
thyroiditis (in individuals with a genetic trait linked to 
autoimmunity) and also lead to iodine-induced hyper-
thyroidism (5) mainly in the elderly (who frequently 
present thyroid nodules). Thus, Camargo and cols. 
(6,7) confirmed that the prevalence of chronic auto-
immune thyroid disease (Hashimoto’s thyroiditis) was 
elevated in an urban population in São Paulo, after five 
years of excessive iodine nutrition (from 1998 to 2004). 
A total of 16.5% of women (all ages) had clinical signs, 
ultrasonographic hypoechogenicity and positive anti-
TPO antibodies, which, taken together, are considered 
to strongly indicate chronic autoimmune thyroiditis. 
Men were also affected (4% of all men) by Hashimoto’s 
thyroiditis. Another study by Duarte and cols. (8) in-
dicated that 8% of 868 children studied in São Paulo 
had echographical evidence of marked hypoechoge-
nicity suggestive of chronic thyroiditis. More recently, 
Duar te and cols. (9) studied 400 elderly patients in São 
Paulo. One third of the patients had urinary iodine ex-
cretion of more than 300 µg I/L urine. Echographic 
studies confirmed that 20.9% of the woman and 8.4% 
of the men had marked hypoechogenicity indicative of 
chronic autoimmune thyroiditis. Moreover, overt hy-
pothyroidism (4.3%) and subclinical hypothyroi dism 
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(8.1%) indicated that overall 12.4% of the geriatric 
population had laboratory evidence for diminished thy-
roid function. Taking together the echographic studies 
and the thyroid function tests, we may assume that a 
relatively large proportion of the elderly will develop 
hypothyroidism in the coming years (10). Single and 
multinodular goiters were present in 25.6% and 8.5% of 
this geriatric population, respectively. Hyperthyroidism 
(subclinical and clinical) was confirmed in 6.5% of the 
participants. This figure is considered high compared 
to other population studies (11).
In conclusion, the excessive nutritional iodine intake 
(from 1998 to 2004) may be considered an environ-
mental factor conducive to a high prevalence of both 
Hashimoto’s thyroiditis and iodine-induced hyperthyroi-
dism, as recently received by Papanastasiou and cols. (10).
THE FUTURE OF THE SALT IODINATION PROGRAM
The Ministry of Health recently created a multi-center 
Committee for the Prevention and Control of Iodine 
Deficiency Disorders. This Committee, comprising 
Members of the Ministry of Health, the Anvisa, Uni-
cef, the salt industry, WHO and Universities (includ-
ing the University of São Paulo, GMN), suggested that 
a national Survey of schoolchildren for urinary iodine 
excretion were conducted in 2008-2009. This survey 
was called PNAISAL (Pesquisa Nacional da Avaliação 
de Impacto da Iodação do Sal) and would constitute a 
broad and informative survey in children of each State, 
proportional to the respective population (based on the 
2006 census). The total number of children to be visited 
and examined was estimated at 40,000 (later reduced 
to 20,000). Urine specimens were to be collected as 
well as salt samples from domestic sources. At the end 
of 2008, around 14,000 children had been surveyed 
and urine samples collected. Results are still pending 
but are certain to indicate the need for a change in the 
Salt Iodination Program. Table 3 depicts the data on 
consumption of salt for human use, in both domestic 
use (direct) and industrialized products (indirect). It is 
noteworthy that Brazilians are consuming an increasing 
amount of salt through this latter source in the past few 
years. In the last meeting of the Committee, it was pro-
posed that the iodine concentration in salt for human 
use should be lowered to 20-40 mg/kg of salt. This 
was criticized by the salt industry representatives for the 
range between the upper and lower limits was deemed 
too narrow. As the analytical method for determining 
iodine in salt has an intra-assay constant variation, the 
Committee decided to study a proposal to allow salt 
samples containing  15 mg I/kg or up to 45 mg/kg to 
be considered acceptable, with salt producers  not being 
subject to fines within these limits. 
Moderate iodine deficiency (20-49 mg/L)
Mild iodine deficiency (50-99 mg/L)
Optimal (100-199 mg/L)
Risk of iodine-induced hyperthyroidism (200-299 mg/L)
Risk of adverse health consequences (> 300 mg/L)
No data
Figure 1. Worldwide degree of public health significance of iodine nutrition based on median urinary iodine (data from 2007). Note that Brazil is indicated as at risk of adverse 
health consequences due to excessive iodine intake. Source: De Benoist and cols. (12).
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CONCLUSIONS
The salt iodination programme has come a long way 
since the first flawed efforts in 1955. According to the 
latest WHO report, by De Benoist and cols. (12), the 
Americas have shown a marked improvement in io-
dine nutrition since 2003, with less than 10% of the 
whole population presenting urinary iodine excretion 
of less than 100 µg iodine/L (13). Nevertheless, Brazil 
is listed as a country in which iodine intake is more 
than adequate (or even excessive) with a median uri-
nary iodine intake greater than 200 µg I/L (14), which 
indicates that susceptible groups within the population 
might be exposed to the risks of excessive nutritional 
iodine (Figure 1). It is envisaged that upon completion 
of the PNAISAL programme, we will have an excellent 
tool at our disposal to determine the concentration of 
iodine in salt for human use. Continuous monitoring 
and surveillance will be necessary to keep our children 
and the population as a whole on an adequate iodine 
supply through salt. 
Disclosure: no potential conflict of interest relevant to this article 
was reported.
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